DR. DAVID ERWIN KLEINER, M.D., PH.D.
Medical Practice in Bethesda, MD

License number
Maryland D0039670
Category
Medical Practice
Type
Anatomic Pathology
Address
Address 2
10 Center Dr Building 10 ROOM 2N212, Bethesda, MD 20892
4718 Arbutus Ave, Rockville, MD 20853
Phone
(301) 594-2942
(301) 480-9488 (Fax)
(301) 946-8976

Personal information

See more information about DAVID ERWIN KLEINER at radaris.com
Name
Address
Phone
David Kleiner, age 64
4718 Arbutus Ave, Rockville, MD 20853
(301) 946-8976
David E Kleiner, age 65
4718 Arbutus Ave, Rockville, MD 20853
(301) 846-8976
(301) 946-8976

Professional information

See more information about DAVID ERWIN KLEINER at trustoria.com
David Erwin Kleiner Photo 1
David Erwin Kleiner, Bethesda MD

David Erwin Kleiner, Bethesda MD

Specialties:
Pathology, Anatomic Pathology, Physical Medicine & Rehabilitation
Work:
National Institutes Of Health
10 Ctr Dr, Bethesda, MD 20892
Education:
University of Chicago (1988)


David E Kleiner Photo 2
Dr. David E Kleiner, Bethesda MD - MD (Doctor of Medicine)

Dr. David E Kleiner, Bethesda MD - MD (Doctor of Medicine)

Specialties:
Anatomic Pathology
Address:
10 Ctr Dr SUITE 10, Bethesda 20892
(301) 594-2942 (Phone), (301) 480-9488 (Fax)
Certifications:
Anatomic Pathology, 1992
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1988
Lab Of Path Nci


David Kleiner Photo 3
N-Formyl Peptide Receptor Mediation Of Platelet Chemotaxis Toward Injured Cells And Activation Of Immune Response

N-Formyl Peptide Receptor Mediation Of Platelet Chemotaxis Toward Injured Cells And Activation Of Immune Response

US Patent:
2006017, Aug 3, 2006
Filed:
Oct 4, 2002
Appl. No.:
10/263791
Inventors:
Allan Kirk - Potomac MD, US
Meggan Czapiga - Washington DC, US
David Kleiner - Rockville MD, US
International Classification:
A61K 39/395, A61K 38/17
US Classification:
424143100, 514012000
Abstract:
The present invention relates to N-formyl peptides that induce an immune response, specifically, stimulating mobilization of platelets to a site of injury, thereby healing wounds. Further, the invention relates to N-formyl peptide receptor inhibitors, specifically N-formyl peptide receptor antibodies, that inhibit an immune response, thereby blocking inflammation and the mobilization of platelets and other phagocytic cells to a site of injury.